Caledonian Holdings PLC Interim Results Highlight Strategic Shift and New Financial Services Investments

Interim results: strategy reset, fresh capital and two financial services deals

Caledonian Holdings PLC has published unaudited interim results for the six months to 30 September 2025. This period is all about the strategic reset into financial services, the first two investments under that plan, and making sure there is enough capital to execute.

Below I break down the key numbers, what the new deals mean, and the risks to watch as the story develops.

Headline numbers for H1 FY2026

The income statement is still in the red, but losses have narrowed sharply versus last year as fair value hits eased. Cash and net assets moved up, helped by placings and portfolio activity.

Metric	H1 FY2026	H1 FY2025
Loss after tax	£595,000	£2,736,000
Fair value movement on investments	£(263,000)	£(2,603,000)
Administrative expenses	£294,000	£139,000
Finance income	£37,000	£6,000
Net assets (period end)	£3.852 million	£3.802 million
Cash and cash equivalents (period end)	£1.091 million	£103,000
Basic and diluted loss per share	0.0008 pence	0.0155 pence

Note: the cash flow statement shows period-end cash of £1.091 million. The chairman’s statement also references £1,019,217 at the balance sheet date – the RNS does not reconcile this difference.

Cash, funding runway and the Yorkville facility

Cash increased to £1.091 million at 30 September 2025 from £787,000 at the start of the period, mainly thanks to £1.171 million proceeds from share issues and £286,000 of investment disposals, offset by operating outflows.

Post period end, Caledonian secured a £3.5 million funding package from Yorkville. The company says this is to support further near term funding for AlbaCo, other investment opportunities and working capital. The detailed terms sit in the 14 November 2025 announcement, but the headline is clear – runway has been extended to keep executing the new strategy.

AlbaCo – cornerstone investment with stepped-up support

AlbaCo is the flagship move under the new financial services focus, and Caledonian has materially increased support since September.

• June 2025 – initial £1,000,000 investment (cash plus shares).
• September 2025 – £120,000 prepayment to AlbaCo.
• October 2025 – subscription agreement totalling £1,000,000 to support near-term working capital and AlbaCo’s authorisation capital raise. Fully drawn in October and November 2025.
• 18 December 2025 – further £450,000 prepayment towards participation in Alba’s forthcoming regulatory capital fundraising. Drawn immediately.

That brings funds advanced to AlbaCo since September 2025 to £1.57 million. The RNS positions AlbaCo as central to the plan, with funding intended to bridge it through regulatory and capital raising milestones. The near-term dependency on AlbaCo’s progress is a positive if it executes, but it is also a concentration risk if timelines slip.

Aspire Commerce Group – a bold second step and a policy shift

Caledonian has agreed to acquire 100% of Aspire Commerce Group Limited, subject to conditions. This is a significant pivot point because the current investing policy does not allow majority investments. The board will seek shareholder approval at the upcoming AGM to adopt a new policy that permits majority stakes.

To facilitate operations in the meantime, Caledonian put in place a working capital facility of up to £600,000 for Aspire, of which £300,000 has been advanced (as per the 26 November 2025 announcement). If shareholders back the policy change, Caledonian moves from a passive investor to an integrated, technology-enabled financial services investment group that can own and control assets.

Portfolio reshaping and fair value swings

Management continued tidying the legacy quoted portfolio to recycle capital into the new strategy. Fair value losses on investments were £263,000 in the half, far lower than the £2.603 million hit in the comparable period.

• EnSilica plc – sold 100,000 shares at an average 33p, gross proceeds £32,712. Remaining holding 141,707 shares.
• Finseta plc – sold 50,000 shares at an average 35p, gross proceeds £17,405. Remaining holding 150,000 shares.
• Skillcast Group plc – fully exited at 42p, gross proceeds £234,879.
• Conduit Pharma Inc – fully exited at 13p, gross proceeds £1,299.

Administrative expenses rose to £294,000 from £139,000, reflecting the cost of building a new investment platform. Derivative assets (warrants held over investee companies) were valued at £10,000.

Capital structure: placings, warrants and options

There has been substantial issuance to capitalise the new plan and add incentive alignment.

• 14 April 2025 – issued 10,920,000,000 shares at 0.0025p. 5,460,000,000 investor warrants at 0.0075p. Broker warrants of 1,889,121,000 at 0.0025p.
• 15 July 2025 – raised £1.05 million via 29,999,999,998 shares at 0.0035p. 14,999,999,999 warrants at 0.0075p, exercisable for two years.
• Options – 13,325,883,776 options granted to Jim McColl at 0.0025p, valid for two years, vesting on completion of the first post-appointment investment. Share-based payment charge in the period £75,268.
• Shares in issue at 30 September 2025 – 103,267,796,702 Ordinary Shares of 0.001p each.

For investors, the positives are funding flexibility and management alignment. The flipside is clear dilution potential from the large block of warrants and options sitting over the capital structure.

Balance sheet anchors: investments and receivables

Investments were carried at £1.837 million at period end, after £1,000,000 additions, £310,000 disposals and a £263,000 fair value loss. A non-current loan receivable from Bixx Tech Limited stood at £750,000, representing deferred consideration from 2020, discounted at 4.5% and subject to distribution arrangements via Special Deferred Shares.

Current receivables included £120,000 owed from AlbaCo and other debtors of £50,000.

My take: why this matters now

This readout shows Caledonian genuinely moving from a legacy micro-cap portfolio into a defined financial services platform. Two early moves – AlbaCo and Aspire – give direction and potential deal flow. Losses have narrowed, and the £3.5 million Yorkville package adds firepower to keep momentum.

Risks are real. Execution now leans heavily on AlbaCo’s regulatory and capital milestones. The Aspire acquisition needs shareholder approval to change the investing policy, and there is meaningful dilution capacity from warrants and options that could weigh on the share price if exercised or if more equity is needed. Fair value accounting also means reported profit will remain sensitive to market moves.

Net-net, this is a cleaner, more purposeful story than a year ago. If management lands the policy change, closes Aspire and shepherds AlbaCo through its raise, the group will look materially different by mid-2026. Until then, expect newsflow on funding, regulatory progress and portfolio reshaping to drive sentiment.

What to watch next

• Shareholder vote on the new investing policy to permit majority stakes.
• Completion and integration plans for Aspire Commerce Group Limited.
• AlbaCo funding and regulatory authorisation progress; timing of Caledonian’s participation in the regulatory capital raise.
• Deployment of the £3.5 million Yorkville facility and any terms-related disclosures.
• Further disposals of legacy holdings and any new financial services investments.